Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1123118011 | 11231180 | 11 | F | 20130124 | 20160816 | 20150701 | 20160830 | EXP | CA-PFIZER INC-2015214504 | PFIZER | 50.00 | YR | M | Y | 63.00000 | KG | 20160830 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1123118011 | 11231180 | 1 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, Q.WK | N | 0 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | |||||
| 1123118011 | 11231180 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 25 MG, WEEKLY | N | 11719 | 25 | MG | SOLUTION FOR INJECTION | /wk | |||||
| 1123118011 | 11231180 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | N | 11719 | TABLET | |||||||||
| 1123118011 | 11231180 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | N | 7073 | ||||||||||
| 1123118011 | 11231180 | 5 | SS | ABATACEPT | ABATACEPT | 1 | Subcutaneous | 125 MG, UNK | U | 0 | 125 | MG | |||||||
| 1123118011 | 11231180 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | N | 0 | TABLET | ||||||||
| 1123118011 | 11231180 | 7 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | UNK | N | 0 | SOLUTION FOR INJECTION | ||||||||
| 1123118011 | 11231180 | 8 | SS | NAPROSYN | NAPROXEN | 1 | 500 MG, 2X/DAY | U | 0 | 500 | MG | BID | |||||||
| 1123118011 | 11231180 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 1123118011 | 11231180 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | 20 MG, DAILY | U | 0 | 20 | MG | ||||||||
| 1123118011 | 11231180 | 11 | SS | PREDNISONE. | PREDNISONE | 1 | 2.5 MG, WEEKLY | U | 0 | 2.5 | MG | /wk | |||||||
| 1123118011 | 11231180 | 12 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 125 MG, WEEKLY | N | 0 | 125 | MG | /wk | ||||||
| 1123118011 | 11231180 | 13 | C | NAPRELAN | NAPROXEN SODIUM | 1 | 1000 MG, 1X/DAY | 0 | 1000 | MG | QD | ||||||||
| 1123118011 | 11231180 | 14 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, 3 TIMES/WK | 0 | 5 | MG | |||||||||
| 1123118011 | 11231180 | 15 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, 4 DAYS A WEEK | 0 | 5 | MG | |||||||||
| 1123118011 | 11231180 | 16 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 1123118011 | 11231180 | 17 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 1123118011 | 11231180 | 18 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 1123118011 | 11231180 | 19 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 1123118011 | 11231180 | 20 | C | LOVASTATIN. | LOVASTATIN | 1 | UNK | 0 | TABLET | ||||||||||
| 1123118011 | 11231180 | 21 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 1123118011 | 11231180 | 22 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 1123118011 | 11231180 | 23 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 1123118011 | 11231180 | 24 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 1123118011 | 11231180 | 25 | C | NAPROXEN. | NAPROXEN | 1 | UNK | 0 | |||||||||||
| 1123118011 | 11231180 | 26 | C | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1123118011 | 11231180 | 1 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 2 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 4 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 6 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 7 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 8 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 9 | Rheumatoid arthritis |
| 1123118011 | 11231180 | 12 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1123118011 | 11231180 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1123118011 | 11231180 | Activities of daily living impaired | |
| 1123118011 | 11231180 | Anaemia | |
| 1123118011 | 11231180 | Arthralgia | |
| 1123118011 | 11231180 | Back disorder | |
| 1123118011 | 11231180 | Blood albumin decreased | |
| 1123118011 | 11231180 | C-reactive protein increased | |
| 1123118011 | 11231180 | Condition aggravated | |
| 1123118011 | 11231180 | Diverticular perforation | |
| 1123118011 | 11231180 | Diverticulum | |
| 1123118011 | 11231180 | Drug ineffective | |
| 1123118011 | 11231180 | Drug intolerance | |
| 1123118011 | 11231180 | Hand deformity | |
| 1123118011 | 11231180 | Headache | |
| 1123118011 | 11231180 | Joint range of motion decreased | |
| 1123118011 | 11231180 | Joint stiffness | |
| 1123118011 | 11231180 | Joint swelling | |
| 1123118011 | 11231180 | Lymphadenopathy | |
| 1123118011 | 11231180 | Musculoskeletal stiffness | |
| 1123118011 | 11231180 | Neck mass | |
| 1123118011 | 11231180 | Pain | |
| 1123118011 | 11231180 | Pain in extremity | |
| 1123118011 | 11231180 | Peripheral swelling | |
| 1123118011 | 11231180 | Rheumatoid arthritis | |
| 1123118011 | 11231180 | Thrombocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1123118011 | 11231180 | 1 | 20130124 | 2013 | 0 | |
| 1123118011 | 11231180 | 12 | 20150620 | 0 | ||
| 1123118011 | 11231180 | 24 | 20150704 | 0 |